GlassScriptPhysician profile
Kiran Patil
NPI 1538585880
$7,539.50
in general payments reported to CMS, 2019-2025
46 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,722 · 2020: $710 · 2021: $283 · 2022: $400 · 2023: $295 · 2024: $1,944 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,424.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,059.90 | 2021-2025 | |
| Ucb, INC. | $923.88 | 2019-2025 | Briviact, Nayzilam, Zilbrysq |
| Teva Pharmaceuticals USA, INC. | $521.98 | 2019-2025 | Austedo Xr, Austedo Xr |
| Novartis Pharmaceuticals Corporation | $484.57 | 2019-2023 | |
| Eisai INC. | $469.31 | 2023-2025 | |
| Emd Serono, INC. | $328.69 | 2019-2025 | Mavenclad |
| Csl Behring | $319.35 | 2019-2022 | |
| Lilly USA, LLC | $298.37 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Acorda Therapeutics, INC | $260.93 | 2019-2024 | Inbrija |
| Sunovion Pharmaceuticals INC. | $249.08 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $241.92 | 2019-2025 | Nuplazid |
| Biogen, INC. | $210.69 | 2019-2025 | Vumerity, Tysabri |
| Argenx US, INC. | $204.72 | 2022-2024 | Vyvgart Hytrulo |
| Lundbeck LLC | $195.17 | 2019-2025 | Vyepti |
| Genzyme Corporation | $194.20 | 2019-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiran Patil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.